Taking Mounjaro Every 8 Days: What the Dosing Schedule Actually Says

The misconception: 'a day either side makes no real difference'

The idea that Mounjaro's injection interval is loosely flexible is understandable. Weekly medicines often tolerate a day's grace in either direction, and people reasonably assume GLP-1 treatments work the same way. Partly true, partly not. Tirzepatide (the active ingredient in Mounjaro) has a half-life of roughly five days, so blood levels do not cliff-edge overnight if an injection is one day late. The Patient Information Leaflet acknowledges this: if you miss a dose and the next scheduled injection is more than four days away, you take the missed dose and then resume your normal day. That guidance is in the Mounjaro SmPC on the eMC.

What the licence does not support is routinely spacing injections to every eight days by design. The seven-day interval is what the SURMOUNT clinical programme was built on. Drifting the schedule habitually means you are no longer on the treatment that was studied. Over time, that can mean slightly lower average exposure to the medicine and, potentially, less consistent appetite suppression between doses. A one-off day-eight injection is very different from making eight days your new norm.

If your usual injection day has shifted and you are unsure whether to correct back or carry on, that is a conversation for your prescriber, not something to resolve by trial and error.

Why the seven-day interval is built into the pharmacology

Tirzepatide is a dual GIP and GLP-1 receptor agonist, the only medicine of its kind licensed for weight management in the UK. Its design means a single subcutaneous dose reaches peak plasma concentration within roughly one to two days and then slowly declines across the rest of the week, providing sustained appetite suppression and slower gastric emptying throughout. The seven-day injection rhythm is calibrated to keep trough levels (the lowest point just before the next dose) within a therapeutically useful range.

When that trough is allowed to extend further, the steady-state exposure the body relies on is disrupted. You may notice this practically: some people report that hunger returns more sharply in the day or two before an injection, and stretching that window by another day can amplify the effect. It does not mean the medicine has stopped working, but it does suggest the interval matters more than it might appear on the surface.

Understanding this helps explain why the NHS's guidance on tirzepatide is clear that doses should be taken on the same day each week where possible. Picking a consistent day (a Monday evening routine, say) removes the arithmetic entirely.

What to do if your injection day drifts to day eight (or later)

Life does not run on a pharmaceutical timetable. You might travel, forget, run out of needles, or simply lose track of the day. Here is what the licensed guidance covers.

If your next scheduled injection is more than four days away and you remember a missed dose: take it as soon as you remember, then return to your normal weekly day. If your next scheduled injection is four days away or fewer: skip the missed dose and take the next one on your usual day. Do not take two doses close together to compensate. The Patient Information Leaflet in your pen box sets this out precisely, and it is worth reading it rather than relying on any secondary source, including this page.

If you find yourself regularly drifting to eight days or beyond, the practical fix is to reset your injection day, your prescriber can advise on the cleanest way to do that. Some people find linking the injection to a fixed weekly anchor (Sunday evening, before the working week begins) keeps the schedule reliably on track. Changing your weekly day is clinically straightforward but worth flagging to your prescribing team so it is recorded.

Questions about the cost of staying on treatment are reasonable too. Our Mounjaro pricing page covers what private treatment includes in a single transparent cost.

How your prescriber thinks about dosing intervals at repeat review

At nume, every repeat order goes through a clinical review before it is approved, a named prescriber reads your update, not a system that rubber-stamps it. That review considers your current dose, how your body has responded, and whether you have reported any concerns about timing or tolerability. If you have been regularly injecting on day eight, mentioning it gives your prescriber the full picture.

The same clinical logic applies when a dose increase is on the table. Moving up the schedule (from 5mg to 7.5mg, for instance) depends on how the current dose has been tolerated. Irregular timing can make that picture harder to read. Our clinical team follows the licensed titration pathway, which starts at 2.5mg and moves up in steps when the previous dose is well tolerated, typically at four-week intervals.

If you are exploring whether Mounjaro is right for you in the first place, our BMI eligibility guide covers the licensed thresholds. And if you are wondering how slightly different intervals interact with treatment (injecting every six days, every ten days, or even every five days with Mounjaro, and the equivalent question of whether a five-day interval works for tirzepatide) those pages work through the same pharmacological logic from different angles.

The short version: stick to seven days where you can, use the PIL's missed-dose rules when life intervenes, and talk to your prescriber if the pattern keeps slipping. That is what clinical oversight is for.